If slower recovery and lower energy have you asking about growth hormone, CJC-1295 ipamorelin is one option your provider can evaluate against your IGF-1 labs, a blood marker of growth hormone activity.
If slower recovery and lower energy have you asking about growth hormone, CJC-1295 ipamorelin is one option your provider can evaluate against your IGF-1 labs, a blood marker of growth hormone activity.
BEST FOR
Adults looking for growth hormone support guided by lab work
METHOD
Injection, as dispensed by our pharmacy partner
FREQUENCY
Set by your provider from your IGF-1 labs
All information regarding products and services on this site are for educational purposes only. Dynamis Online is not a pharmacy and does not manufacture, distribute, or ship any medications discussed on this site. Our licensed medical professionals work with you to develop a personalized treatment plan that fits your unique health goals. All products and medications are manufactured and distributed by independent, third-party vendor pharmacies and are routinely inspected by both state and federal agencies for safety and efficacy.
Neither peptide is a growth hormone. Both prompt your pituitary to release its own, so your body’s normal feedback loop keeps working.
CJC-1295 acts on the receptor for growth hormone-releasing hormone, and ipamorelin acts on the ghrelin receptor. Pairing them is meant to hit both routes that trigger a growth hormone pulse.
In animal research, ipamorelin raised growth hormone without the jump in ACTH and cortisol (stress-hormone signals) that older peptides such as GHRP-6 caused.
Growth hormone signaling shows up in your IGF-1 level, so your provider judges the protocol by a lab value you can see.
CJC-1295 is a lab-made analog of growth hormone-releasing hormone, and ipamorelin activates the ghrelin receptor. Combined in one injection, they are designed to signal your pituitary to release growth hormone through two routes at once.
That makes the pair different from prescription HGH, which supplies the hormone directly. Neither CJC-1295 nor ipamorelin is FDA-approved for any use.
We start with what brought you to this combination, what you have already tried, and your full health history.
Your provider orders comprehensive lab work, including IGF-1, before recommending anything, because that result decides whether a growth hormone peptide makes sense at all.
If the pair fits, your provider sets the dose and schedule from your labs and history then walks you through the injection. If Sermorelin or tesamorelin suits your goals better, you hear that first.
Your Personal Health Coach replies within 2 hours on any channel, and follow-up labs tell your provider whether to hold, adjust or stop.
Published research shows ipamorelin raised growth hormone in healthy men. The two have been studied separately rather than as a pair, and controlled evidence on muscle, fat or recovery is limited. Your provider tracks your own response through follow-up IGF-1 labs and adjusts from there.
Side effects reported with growth hormone-stimulating peptides include injection-site redness, flushing, headache and water retention. Raising growth hormone can also push blood sugar up, which is one reason your provider rechecks your labs during the protocol.
No, neither CJC-1295 or ipamorelin is FDA-approved. Your provider decides whether either one fits you after reviewing your IGF-1 labs and health history, and our guide to how peptide legality works explains what that means for patients.
Your provider sets your CJC-1295 and ipamorelin dose from your IGF-1 labs, health history and goals. No standard dose has been established for the two together, so your provider adjusts it as follow-up labs come in.
Sermorelin and tesamorelin both act on the growth hormone-releasing hormone receptor alone, while CJC-1295 ipamorelin pairs that signal with a second one through the ghrelin receptor. Tesamorelin is FDA-approved only for reducing abdominal fat in HIV-associated lipodystrophy. Your provider can tell you which option fits your goals and labs.
